Form 4: Franklin Covey CFO Granted 12,406 Shares in FY26 LTIP

Sentiment:

Insider Stock Acquisition Report


Franklin Covey Co.'s CFO, Jessica Betjemann, was granted 12,406 common shares as part of the company's Fiscal Year 2026 Long-Term Incentive Plan.

Summary

  • Jessica Betjemann, Chief Financial Officer of Franklin Covey Co. (FC), acquired 12,406 common shares.
  • The transaction occurred on November 13, 2025, and was reported on November 17, 2025.
  • The shares were acquired at a price of $0, indicating they were a grant rather than a purchase.
  • This grant is part of the company's Fiscal Year 2026 Long-Term Incentive Plan (LTIP).
  • The acquired shares will vest in three tranches: November 2026, November 2027, and November 2028.
  • Following this transaction, Jessica Betjemann beneficially owns a total of 15,342 common shares.
  • The transaction was made pursuant to a Rule 10b5-1(c) plan, a pre-arranged plan for the purchase or sale of equity securities.

Sentiment

Score: 6

Explanation: The filing reports a routine executive compensation grant, which is generally a neutral to slightly positive event as it aligns management incentives with shareholder interests. It does not contain information that would significantly alter the company's financial outlook or operational performance.

Positives

  • The grant of shares to the CFO aligns management's interests with those of shareholders, incentivizing long-term performance.
  • The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned and transparent approach to executive compensation.

Future Outlook

The grant of shares under the FY26 LTIP with vesting through November 2028 indicates a long-term commitment to the executive and ties future compensation to the company's performance over several fiscal years.

Industry Context

Executive equity grants are a standard practice across industries to incentivize leadership and align their financial interests with shareholder value creation. The use of a Long-Term Incentive Plan (LTIP) is common for retaining key talent and promoting sustained performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AdherenceThe transaction was made pursuant to a Rule 10b5-1(c) plan, which allows insiders to set up pre-arranged plans to buy or sell company stock to avoid accusations of insider trading.11/13/2025Enhances transparency and reduces potential for insider trading concerns related to executive stock transactions.

Related Party Transactions

  • The grant of 12,406 common shares to CFO Jessica Betjemann as part of the FY26 LTIP constitutes an executive compensation transaction, which is a form of related party dealing.

Stakeholder Impact

  • Shareholders: The grant aligns the CFO's financial incentives with the long-term performance of the company, potentially benefiting shareholder value.
  • Employees: May signal stability in executive leadership and a commitment to long-term strategic goals.

Next Steps

  • The granted shares will vest in three equal tranches in November 2026, November 2027, and November 2028.

Key Dates

DateDescription
11/13/2025Date of transaction where 12,406 common shares were granted to the CFO.
11/17/2025Date the Form 4 was filed with the SEC.
11/01/2026Approximate date of the first vesting tranche for the FY26 LTIP shares.
11/01/2027Approximate date of the second vesting tranche for the FY26 LTIP shares.
11/01/2028Approximate date of the third vesting tranche for the FY26 LTIP shares.

Keywords

Franklin Covey, FC, Jessica Betjemann, CFO, Insider Trading, Stock Grant, Executive Compensation, Long-Term Incentive Plan, LTIP, Rule 10b5-1, SEC Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.